Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Beta-Blocker Influences on Inflammatory and Neural Responses to Stress

NCT06263452 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.

NCT NCT06263452
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06263452 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Beta-Blocker Influences on Inflammatory and Neural Responses to Stress
Lead sponsor
University of North Carolina, Chapel Hill
Phase
Phase 4
Overall status
Recruiting
Start date
May 1, 2024
Completion date
May 31, 2026
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease